Details for New Drug Application (NDA): 020402
✉ Email this page to a colleague
NDA 020402 describes ADVIL MIGRAINE LIQUI-GELS, which is a drug marketed by Haleon Us Holdings and is included in one NDA. It is available from four suppliers. Additional details are available on the ADVIL MIGRAINE LIQUI-GELS profile page.
The generic ingredient in ADVIL MIGRAINE LIQUI-GELS is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and forty suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
The generic ingredient in ADVIL MIGRAINE LIQUI-GELS is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and forty suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 020402
| Tradename: | ADVIL MIGRAINE LIQUI-GELS |
| Applicant: | Haleon Us Holdings |
| Ingredient: | ibuprofen |
| Patents: | 0 |
Pharmacology for NDA: 020402
| Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 020402
Suppliers and Packaging for NDA: 020402
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ADVIL LIQUI-GELS | ibuprofen | CAPSULE;ORAL | 020402 | NDA | Haleon US Holdings LLC | 0573-0149 | 0573-0149-04 | 2 PACKET in 1 BLISTER PACK (0573-0149-04) / 2 CAPSULE, LIQUID FILLED in 1 PACKET |
| ADVIL LIQUI-GELS | ibuprofen | CAPSULE;ORAL | 020402 | NDA | Haleon US Holdings LLC | 0573-0149 | 0573-0149-13 | 1 BOTTLE in 1 CARTON (0573-0149-13) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | CAPSULE;ORAL | Strength | EQ 200MG FREE ACID AND POTASSIUM SALT | ||||
| Approval Date: | Apr 20, 1995 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | OTC | Dosage: | CAPSULE;ORAL | Strength | EQ 200MG FREE ACID AND POTASSIUM SALT | ||||
| Approval Date: | Mar 16, 2000 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
